Skip to main content

Using Chromeleon 7 Chromatography Data System to Comply with 21 CFR Part 11

21 CFR Part 11 requires Food and Drug Administration (FDA)-regulated industries, including medical device manufacturers, drug makers, biotech companies and biologics developers, to have validation documentation and implement controls such as audit trails and electronic signatures. Implementing a chromatography data system (CDS) that provides all of the necessary functionality built-in to one package can significantly reduce the effort required to achieve compliance with 21 CFR Part 11.

Premium Access

To access this content please enter your details in the fields below.

Media Partners